Upgrade to SI Premium - Free Trial

Relay Therapeutics (RLAY) PT Raised to $19 at Citizens -Triplet Update a 'Strong Positive'

April 28, 2026 4:12 AM
Citizens analyst Silvan Turkcan raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $19.00 (from $17.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change